MPM Bioventures 2018, L.P. 的 Form 4 申報
Entrada Therapeutics, Inc.（TRDA），2026/9/9 申報
- 申報編號
- 0001231919-26-001156
- 申報時間
- 2026/9/9 19:24 ET
- 交易日
- 2026/9/4-9/9
- 申報延遲
- 5 天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 3 筆非衍生性交易。公開市場賣出合計 $190.6 萬。交易後 5 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| MPM Bioventures 2018, L.P.CIK 0001729505 | 持股 10% 以上大股東 |
| MPM BioVentures 2018 GP LLCCIK 0001818701 | 持股 10% 以上大股東 |
| MPM BioVentures 2018 LLCCIK 0001818702 | 持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Price represents the weighted average sale price of the shares sold. The sale price ranged from $7.01 to $7.16 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Price represents the weighted average sale price of the shares sold. The sale price ranged from $6.97 to $7.70 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
表 I 有 1 筆交易的價格引用這則附註。
- F9
Price represents the weighted average sale price of the shares sold. The sale price ranged from $7.02 to $7.54 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
表 I 有 1 筆交易的價格引用這則附註。
備註
See Form 4 for MPM BioVentures 2014, L.P for additional members of this joint filing.